Skip to content
Clinical Trials – home

Universitaet Leipzig

Verifiedinfo

Germany Liebigstrasse 20, 04103 Leipzig, Germany

  • 175 trials recruiting
  • Acute myeloid leukaemia · Myelodysplastic syndrome · Oesophageal adenocarcinoma
  • Adults and children

About Specializations

Universitaet Leipzig in Leipzig, Germany specialises in clinical trials of conditions such as Acute myeloid leukaemia, Myelodysplastic syndrome, Oesophageal adenocarcinoma, Ischaemic stroke, and other specialisations. This site conducts important research.

Main research areas of the site

Skin and Connective Tissue Diseases

At Universitaet Leipzig, clinical research in Dermatology, Venereology, and Allergology is centered on skin and connective tissue diseases, with a strong focus on ulcerative pyoderma gangrenosum. The trials are designed to assess whether new treatment approaches can improve outcomes for patients living with this rare and difficult-to-treat inflammatory condition.

  • Studies focused on ulcerative pyoderma gangrenosum and related inflammatory skin disorders
  • Research evaluating the effectiveness and safety of emerging therapies
  • Clinical work aimed at improving treatment options for complex dermatologic disease

With 6 clinical trials and 106 investigators contributing to the program, the site supports focused research on better therapies for this rare skin disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Liebigstrasse 2004103 LeipzigGermany
Recruiting now
175 trials
Conditions studied
235
Partner status
Verified

More sites in LeipzigGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

429 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Loratadine
  • Sponsor:Pfizer Inc.
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Daiichi Sankyo Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.